Affordable Access

Antibacterial activity of azithromycin against Brucella melitensis.

Authors
  • Qadri, S M
  • Halim, M A
  • Ueno, Y
  • Abumustafa, F M
  • Postle, A G
Type
Published Article
Journal
Chemotherapy
Publication Date
Jan 01, 1995
Volume
41
Issue
4
Pages
253–256
Identifiers
PMID: 7555205
Source
Medline
License
Unknown

Abstract

In vitro antibacterial activity of the new macrolide azithromycin was tested against 116 strains of Brucella melitensis, isolated from 115 patients in a major tertiary care referral center. Eighty-seven percent of the strains were inhibited by 1.0 mg/l and all the 116 strains by 2.0 mg/l of azithromycin. Comparison was made with tetracycline, gentamicin, trimethoprim-sulfamethoxazole, rifampicin and ciprofloxacin. All the isolates were susceptible to gentamicin, tetracycline, trimethoprim-sulfamethoxazole, rifampicin. One hundred and fifteen of the 115 strains were also susceptible to ciprofloxacin.

Report this publication

Statistics

Seen <100 times